Report cover image

Global CAR T-Cell Therapy Competitive Landscape Professional Research Report 2024

Publisher DIResearch
Published Jun 10, 2024
Length 170 Pages
SKU # DIR18897107

Description

Global CAR T-Cell Therapy Competitive Landscape Professional Research Report 2024



Research Summary

CAR T-cell therapy, or Chimeric Antigen Receptor T-cell therapy, is an innovative immunotherapy approach used to treat certain types of cancer, particularly blood cancers like leukemia and lymphoma. In CAR T-cell therapy, a patient＇s own T cells (a type of immune cell) are collected from their blood and then genetically engineered to express a chimeric antigen receptor (CAR) on their surface. This receptor is designed to recognize and target a specific protein found on the cancer cells. Once the CAR T cells are modified, they are multiplied in the laboratory and then infused back into the patient＇s bloodstream. These engineered T cells can now identify and attack cancer cells, effectively enhancing the immune system＇s ability to combat the disease. CAR T-cell therapy has shown remarkable success in some patients with otherwise challenging-to-treat blood cancers, leading to complete or partial remissions and offering new hope in the field of cancer treatment.

According to DIResearch's in-depth investigation and research, the global CAR T-Cell Therapy market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.

The major global manufacturers of CAR T-Cell Therapy include Novartis, Gilead Sciences, Bristol-Myers Squibb, Johnson & Johnson, JW Therapeutics, FOSUNKite, CARsgen Therapeutics (Pipeline), Autolus Therapeutics(Pipeline), Sorrento Therapeutics(Pipeline), Mustang Bio(Pipeline), Bluebird Bio(Pipeline), Cellectis(Pipeline), Allogene Therapeutics(Pipeline), Celyad(Pipeline) etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of CAR T-Cell Therapy. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global CAR T-Cell Therapy market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the CAR T-Cell Therapy market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of CAR T-Cell Therapy industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of CAR T-Cell Therapy Include:

Novartis

Gilead Sciences

Bristol-Myers Squibb

Johnson & Johnson

JW Therapeutics

FOSUNKite

CARsgen Therapeutics (Pipeline)

Autolus Therapeutics(Pipeline)

Sorrento Therapeutics(Pipeline)

Mustang Bio(Pipeline)

Bluebird Bio(Pipeline)

Cellectis(Pipeline)

Allogene Therapeutics(Pipeline)

Celyad(Pipeline)

CAR T-Cell Therapy Product Segment Include:

CD19 - Targeted

BCMA - Targeted

CAR T-Cell Therapy Product Application Include:

Lymphoma

Multiple Myeloma

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global CAR T-Cell Therapy Industry PESTEL Analysis

Chapter 3: Global CAR T-Cell Therapy Industry Porter’s Five Forces Analysis

Chapter 4: Global CAR T-Cell Therapy Major Regional Market Size and Forecast Analysis

Chapter 5: Global CAR T-Cell Therapy Market Size and Forecast by Type and Application Analysis

Chapter 6: North America CAR T-Cell Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe CAR T-Cell Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China CAR T-Cell Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) CAR T-Cell Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America CAR T-Cell Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa CAR T-Cell Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global CAR T-Cell Therapy Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table of Contents

170 Pages
1 CAR T-Cell Therapy Market Overview
1.1 Product Definition and Statistical Scope
1.2 CAR T-Cell Therapy Product by Type
1.2.1 Global CAR T-Cell Therapy Market Size by Type, 2023 VS 2024 VS 2030
1.2.2 CD19 - Targeted
1.2.3 BCMA - Targeted
1.3 CAR T-Cell Therapy Product by Application
1.3.1 Global CAR T-Cell Therapy Market Size by Application, 2023 VS 2024 VS 2030
1.3.2 Lymphoma
1.3.3 Multiple Myeloma
1.4 Global CAR T-Cell Therapy Market Revenue Analysis (2019-2030)
1.5 CAR T-Cell Therapy Market Development Status and Trends
1.5.1 CAR T-Cell Therapy Industry Development Status Analysis
1.5.2 CAR T-Cell Therapy Industry Development Trends Analysis
2 CAR T-Cell Therapy Market PESTEL Analysis
2.1 Political Factors Analysis
2.2 Economic Factors Analysis
2.3 Social Factors Analysis
2.4 Technological Factors Analysis
2.5 Environmental Factors Analysis
2.6 Legal Factors Analysis
3 CAR T-Cell Therapy Market Porter's Five Forces Analysis
3.1 Competitive Rivalry
3.2 Threat of New Entrants
3.3 Bargaining Power of Suppliers
3.4 Bargaining Power of Buyers
3.5 Threat of Substitutes
4 Global CAR T-Cell Therapy Market Analysis by Regions
4.1 CAR T-Cell Therapy Overall Market: 2023 VS 2024 VS 2030
4.2 Global CAR T-Cell Therapy Revenue and Forecast Analysis (2019-2030)
4.2.1 Global CAR T-Cell Therapy Revenue and Market Share by Region (2019-2024)
4.2.2 Global CAR T-Cell Therapy Revenue Forecast by Region (2025-2030)
5 Global CAR T-Cell Therapy Market Size by Type and Application
5.1 Global CAR T-Cell Therapy Market Size by Type
5.2 Global CAR T-Cell Therapy Market Size by Application
6 North America
6.1 North America CAR T-Cell Therapy Market Size and Growth Rate Analysis (2019-2030)
6.2 North America Key Manufacturers Analysis
6.3 North America CAR T-Cell Therapy Market Size by Type
6.4 North America CAR T-Cell Therapy Market Size by Application
6.5 North America CAR T-Cell Therapy Market Size by Country
6.5.1 US
6.5.2 Canada
7 Europe
7.1 Europe CAR T-Cell Therapy Market Size and Growth Rate Analysis (2019-2030)
7.2 Europe Key Manufacturers Analysis
7.3 Europe CAR T-Cell Therapy Market Size by Type
7.4 Europe CAR T-Cell Therapy Market Size by Application
7.5 Europe CAR T-Cell Therapy Market Size by Country
7.5.1 Germany
7.5.2 France
7.5.3 United Kingdom
7.5.4 Italy
7.5.5 Spain
7.5.6 Benelux
8 China
8.1 China CAR T-Cell Therapy Market Size and Growth Rate Analysis (2019-2030)
8.2 China Key Manufacturers Analysis
8.3 China CAR T-Cell Therapy Market Size by Type
8.4 China CAR T-Cell Therapy Market Size by Application
9 APAC (excl. China)
9.1 APAC (excl. China) CAR T-Cell Therapy Market Size and Growth Rate Analysis (2019-2030)
9.2 APAC (excl. China) Key Manufacturers Analysis
9.3 APAC (excl. China) CAR T-Cell Therapy Market Size by Type
9.4 APAC (excl. China) CAR T-Cell Therapy Market Size by Application
9.5 APAC (excl. China) CAR T-Cell Therapy Market Size by Country
9.5.1 Japan
9.5.2 South Korea
9.5.3 India
9.5.4 Australia
9.5.5 Indonesia
9.5.6 Vietnam
9.5.7 Malaysia
9.5.8 Thailand
10 Latin America
10.1 Latin America CAR T-Cell Therapy Market Size and Growth Rate Analysis (2019-2030)
10.2 Latin America Key Manufacturers Analysis
10.3 Latin America CAR T-Cell Therapy Market Size by Type
10.4 Latin America CAR T-Cell Therapy Market Size by Application
10.5 Latin America CAR T-Cell Therapy Market Size by Country
10.5.1 Mecixo
10.5.2 Brazil
11 Middle East & Africa
11.1 Middle East & Africa CAR T-Cell Therapy Market Size and Growth Rate Analysis (2019-2030)
11.2 Middle East & Africa Key Manufacturers Analysis
11.3 Middle East & Africa CAR T-Cell Therapy Market Size by Type
11.4 Middle East & Africa CAR T-Cell Therapy Market Size by Application
11.5 Middle East & Africa CAR T-Cell Therapy Market Size by Country
11.5.1 Saudi Arabia
11.5.2 South Africa
12 Market Competition by Manufacturers
12.1 Global CAR T-Cell Therapy Market Revenue by Key Manufacturers (2020-2024)
12.2 CAR T-Cell Therapy Competitive Landscape Analysis and Market Dynamic
12.2.1 CAR T-Cell Therapy Competitive Landscape Analysis
12.2.2 Global Key Manufacturers Headquarter and Key Area Sales
12.2.3 Market Dynamic
13 Key Companies Analysis
13.1 Novartis
13.1.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.1.2 Novartis CAR T-Cell Therapy Product Portfolio
13.1.3 Novartis CAR T-Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.2 Gilead Sciences
13.2.1 Gilead Sciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.2.2 Gilead Sciences CAR T-Cell Therapy Product Portfolio
13.2.3 Gilead Sciences CAR T-Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.3 Bristol-Myers Squibb
13.3.1 Bristol-Myers Squibb Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.3.2 Bristol-Myers Squibb CAR T-Cell Therapy Product Portfolio
13.3.3 Bristol-Myers Squibb CAR T-Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.4 Johnson & Johnson
13.4.1 Johnson & Johnson Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.4.2 Johnson & Johnson CAR T-Cell Therapy Product Portfolio
13.4.3 Johnson & Johnson CAR T-Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.5 JW Therapeutics
13.5.1 JW Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.5.2 JW Therapeutics CAR T-Cell Therapy Product Portfolio
13.5.3 JW Therapeutics CAR T-Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.6 FOSUNKite
13.6.1 FOSUNKite Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.6.2 FOSUNKite CAR T-Cell Therapy Product Portfolio
13.6.3 FOSUNKite CAR T-Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.7 CARsgen Therapeutics (Pipeline)
13.7.1 CARsgen Therapeutics (Pipeline) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.7.2 CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Product Portfolio
13.7.3 CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.8 Autolus Therapeutics(Pipeline)
13.8.1 Autolus Therapeutics(Pipeline) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.8.2 Autolus Therapeutics(Pipeline) CAR T-Cell Therapy Product Portfolio
13.8.3 Autolus Therapeutics(Pipeline) CAR T-Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.9 Sorrento Therapeutics(Pipeline)
13.9.1 Sorrento Therapeutics(Pipeline) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.9.2 Sorrento Therapeutics(Pipeline) CAR T-Cell Therapy Product Portfolio
13.9.3 Sorrento Therapeutics(Pipeline) CAR T-Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.10 Mustang Bio(Pipeline)
13.10.1 Mustang Bio(Pipeline) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.10.2 Mustang Bio(Pipeline) CAR T-Cell Therapy Product Portfolio
13.10.3 Mustang Bio(Pipeline) CAR T-Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.11 Bluebird Bio(Pipeline)
13.11.1 Bluebird Bio(Pipeline) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.11.2 Bluebird Bio(Pipeline) CAR T-Cell Therapy Product Portfolio
13.11.3 Bluebird Bio(Pipeline) CAR T-Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.12 Cellectis(Pipeline)
13.12.1 Cellectis(Pipeline) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.12.2 Cellectis(Pipeline) CAR T-Cell Therapy Product Portfolio
13.12.3 Cellectis(Pipeline) CAR T-Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.13 Allogene Therapeutics(Pipeline)
13.13.1 Allogene Therapeutics(Pipeline) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.13.2 Allogene Therapeutics(Pipeline) CAR T-Cell Therapy Product Portfolio
13.13.3 Allogene Therapeutics(Pipeline) CAR T-Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.14 Celyad(Pipeline)
13.14.1 Celyad(Pipeline) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.14.2 Celyad(Pipeline) CAR T-Cell Therapy Product Portfolio
13.14.3 Celyad(Pipeline) CAR T-Cell Therapy Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
14 Industry Chain Analysis
14.1 CAR T-Cell Therapy Industry Chain Analysis
14.2 CAR T-Cell Therapy Industry Raw Material and Suppliers Analysis
14.2.1 Upstream Key Raw Material Supply Analysis
14.2.2 Raw Material Suppliers and Contact Information
14.3 CAR T-Cell Therapy Typical Downstream Customers
14.4 CAR T-Cell Therapy Sales Channel Analysis
15 Research Findings and Conclusion
16 Methodology and Data Source
16.1 Methodology/Research Approach
16.2 Research Scope
16.3 Benchmarks and Assumptions
16.4 Date Source
16.4.1 Primary Sources
16.4.2 Secondary Sources
16.5 Data Cross Validation
16.6 Disclaimer

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us